ResMed, Inc. (RMD)
252.39
+0.89
(+0.35%)
USD |
NYSE |
Dec 11, 16:00
252.36
-0.03
(-0.01%)
After-Hours: 20:00
ResMed Cash from Investing (Quarterly): -52.58M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -502.00M |
| Abbott Laboratories | -457.00M |
| Becton, Dickinson & Co. | -494.00M |
| Insulet Corp. | -31.00M |
| West Pharmaceutical Services, Inc. | -63.30M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 457.32M |
| Cash from Financing (Quarterly) | -230.27M |
| Free Cash Flow | 1.757B |
| Free Cash Flow Per Share (Quarterly) | 2.802 |
| Free Cash Flow to Equity (Quarterly) | 417.00M |
| Free Cash Flow to Firm (Quarterly) | 411.54M |
| Free Cash Flow Yield | 4.73% |